Total Holdings
65
As of Oct 4, 2026
JPMorgan Healthcare Leaders ETF
JDOCNASDAQJPMorgan ChaseEquity
$62.62Today:- (-)1Y +14.06%
As of Oct 16, 2026 close
- Assets (AUM)
- $9.19M
- Expense ratio
- 0.65%
- Dividend yield
- 0.82%
- Holdings
- 65
- 52-week range
- $53.87$64.69
- Volume (live)
- -
- Avg. volume (3M)
- 263
JDOC ETF Holdings: JPMorgan Healthcare Leaders ETF
Every listed position with its portfolio weight, plus sector breakdown and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Top 10 Holdings
50.4%
Share of fund assets
Assets (AUM)
$9.19M
Total fund assets
Expense Ratio
0.65%
Annual management fee
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 53 of 65 JDOC Holdings by Portfolio Weight
Holdings as of Oct 4, 2026. Ticker, name, asset type and portfolio weight for each position. Fund disclosures available to us list the largest 53 positions.
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | AbbVie Inc. | Stock | 8.42% |
| 2 |  | Eli Lilly and Company | Stock | 7.91% |
| 3 |  | Merck & Co., Inc | Stock | 5.43% |
| 4 |  | Johnson & Johnson | Stock | 4.94% |
| 5 |  | Thermo Fisher Scientific Inc | Stock | 4.61% |
| 6 | SWX:NOVN | Novartis AG | Stock | 4.48% |
| 7 | LON:AZN | AstraZeneca PLC | Stock | 3.94% |
| 8 | LSE:AZN | AstraZeneca PLC | Stock | 3.70% |
| 9 |  | UnitedHealth Group Incorporated | Stock | 3.63% |
| 10 |  | Bristol-Myers Squibb Company | Stock | 3.33% |
| 11 |  | Abbott Laboratories | Stock | 2.95% |
| 12 | SWX:ROP | Roche Holding AG | Stock | 2.81% |
| 13 |  | Danaher Corporation | Stock | 2.74% |
| 14 | EBR:ARGX | Argen-X | Stock | 2.61% |
| 15 | LSE:0QIU | Novo Nordisk A/S Class B | Stock | 2.54% |
| 16 | CPH:NOVO.B | Novo Nordisk A/S | Stock | 2.53% |
| 17 | LSE:GSK | GSK plc | Stock | 2.52% |
| 18 |  | IQVIA Holdings Inc | Stock | 2.33% |
| 19 |  | CVS Health Corporation | Stock | 2.20% |
| 20 |  | Cencora, Inc. | Stock | 2.09% |
| 21 | TA:TEVA | Teva Pharmaceutical Industries Ltd | Stock | 1.98% |
| 22 |  | Humana Inc. | Stock | 1.92% |
| 23 |  | Regeneron Pharmaceuticals, Inc | Stock | 1.85% |
| 24 | TYO:4502 | Takeda Pharmaceutical Company Limited | Stock | 1.85% |
| 25 |  | Biogen Inc | Stock | 1.84% |
| 26 |  | Edwards Lifesciences Corporation | Stock | 1.74% |
| 27 | ETR:BAYN | Bayer Aktiengesellschaft | Stock | 1.54% |
| 28 | TLV:TEVA | Teva Pharmaceutical Industries Limited | Stock | 1.52% |
| 29 |  | Insmed Incorporated | Stock | 1.49% |
| 30 |  | Vertex Pharmaceuticals Incorporated | Stock | 1.48% |
| 31 | TSE:4502 | Takeda Pharmaceutical Co. Ltd. | Stock | 1.39% |
| 32 | SWX:SDZ | Sandoz Group AG | Stock | 1.37% |
| 33 | TSE:7741 | Hoya Cor | Stock | 1.28% |
| 34 |  | Cardinal Health, Inc | Stock | 1.27% |
| 35 |  | Charles River Laboratories International, Inc | Stock | 1.17% |
| 36 | ETR:FRE | Fresenius SE & Co. KGaA | Stock | 1.04% |
| 37 |  | Alnylam Pharmaceuticals, Inc | Stock | 0.96% |
| 38 |  | Neurocrine Biosciences, Inc | Stock | 0.82% |
| 39 |  | Centene Corporation | Stock | 0.81% |
| 40 |  | Intuitive Surgical, Inc | Stock | 0.76% |
| 41 |  | BioMarin Pharmaceutical Inc | Stock | 0.69% |
| 42 |  | Medtronic plc | Stock | 0.60% |
| 43 |  | BridgeBio Pharma, Inc | Stock | 0.59% |
| 44 |  | Spyre Therapeutics Inc. | Stock | 0.57% |
| 45 | LSE:CTEC | ConvaTec Group PLC | Stock | 0.56% |
| 46 |  | Ascendis Pharma AS | Stock | 0.55% |
| 47 |  | Boston Scientific Corporation | Stock | 0.54% |
| 48 |  | PTC Therapeutics, Inc | Stock | 0.54% |
| 49 |  | Dyne Therapeutics Inc | Stock | 0.53% |
| 50 | ETR:SRT3 | Sartorius Aktiengesellschaft | Stock | 0.53% |
| 51 |  | CG Oncology, Inc. Common stock | Stock | 0.45% |
| 52 |  | LB Pharmaceuticals Inc Common Stock | Stock | 0.44% |
| 53 |  | Align Technology, Inc | Stock | 0.43% |
Source: Fund holdings disclosures. Data as of Oct 4, 2026. Data sources and methodology
Frequently Asked Questions About JPMorgan Healthcare Leaders ETF Holdings
What are the top holdings in JDOC?
As of Oct 4, 2026, JPMorgan Healthcare Leaders ETF (JDOC) holds 65 securities. The largest are AbbVie Inc. (8.42%), Eli Lilly and Company (7.91%), Merck & Co., Inc (5.43%). The holdings table lists each position by portfolio weight with its ticker, name and asset type.
How concentrated is JDOC's portfolio?
As of Oct 4, 2026, the 10 largest positions make up 50.4% of JDOC's assets. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly.
What is JDOC's sector allocation?
The Sector Allocation chart shows how JDOC distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does JDOC invest in?
JDOC's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is JDOC ETF?
JDOC's diversification can be assessed by reviewing its 65 holdings (as of Oct 4, 2026), sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.